June 3, 2014
RESEARCH TRIANGLE PARK, N.C - Monday, May 19th 2014 [ME NewsWire]
Jefferies 2014 Global Healthcare Conference
(BUSINESS WIRE) Quintiles CFO Kevin Gordon will present at the Jefferies 2014 Global Healthcare Conference on Tuesday, June 3, 2014 in New York City at the Grand Hyatt New York.
The Quintiles presentation will begin at 1:30 p.m. (EDT). Investors may access a live audio webcast of the presentation on the Quintiles’ investor relations website at www.quintiles.com/investors. An archived audio version of the presentation will be available later that day.
About Quintiles
Quintiles (NYSE: Q) is the world’s largest provider of biopharmaceutical development and commercial outsourcing services with a network of more than 29,000 employees conducting business in approximately 100 countries. We have helped develop or commercialize all of the top-50 best-selling drugs on the market. Quintiles applies the breadth and depth of our service offerings along with extensive therapeutic, scientific and analytics expertise to help our customers navigate an increasingly complex healthcare environment as they seek to improve efficiency and effectiveness in the delivery of better healthcare outcomes. To learn more about Quintiles, please visit www.quintiles.com.
Click here to subscribe to Mobile Alerts for Quintiles.
Contacts
Quintiles
Phil Bridges, Media Relations (phil.bridges@quintiles.com)
+ 1.919.998.1653 (office) +1.919.457.6347 (mobile)
Karl Deonanan, Investor Relations (InvestorRelations@quintiles.com)
+1.919.998.2789
Permalink: http://www.me-newswire.net/news/11036/en
RESEARCH TRIANGLE PARK, N.C - Monday, May 19th 2014 [ME NewsWire]
Jefferies 2014 Global Healthcare Conference
(BUSINESS WIRE) Quintiles CFO Kevin Gordon will present at the Jefferies 2014 Global Healthcare Conference on Tuesday, June 3, 2014 in New York City at the Grand Hyatt New York.
The Quintiles presentation will begin at 1:30 p.m. (EDT). Investors may access a live audio webcast of the presentation on the Quintiles’ investor relations website at www.quintiles.com/investors. An archived audio version of the presentation will be available later that day.
About Quintiles
Quintiles (NYSE: Q) is the world’s largest provider of biopharmaceutical development and commercial outsourcing services with a network of more than 29,000 employees conducting business in approximately 100 countries. We have helped develop or commercialize all of the top-50 best-selling drugs on the market. Quintiles applies the breadth and depth of our service offerings along with extensive therapeutic, scientific and analytics expertise to help our customers navigate an increasingly complex healthcare environment as they seek to improve efficiency and effectiveness in the delivery of better healthcare outcomes. To learn more about Quintiles, please visit www.quintiles.com.
Click here to subscribe to Mobile Alerts for Quintiles.
Contacts
Quintiles
Phil Bridges, Media Relations (phil.bridges@quintiles.com)
+ 1.919.998.1653 (office) +1.919.457.6347 (mobile)
Karl Deonanan, Investor Relations (InvestorRelations@quintiles.com)
+1.919.998.2789
Permalink: http://www.me-newswire.net/news/11036/en
No comments:
Post a Comment